Exelixis EXEL
NASDAQ EXEL
$59.02 -0.11 (-0.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Exelixis (EXEL) Interest & Investment Income (2017 - 2026)

Exelixis (EXEL) posted quarterly Interest & Investment Income of $16.1 million for Q2 2026, down 15.46% year-over-year from $19.1 million in Q2 2025, and down 7.45% quarter-over-quarter from $17.4 million in Q1 2026.

Analysis

Exelixis (EXEL) Interest & Investment Income (2017 - 2026) Analysis & Trends

Exelixis' Interest & Investment Income history runs 10 years deep, the most recent figure standing at $16.1 million for Q2 2026.

  • In Q2 2026, Interest & Investment Income fell 15.46% year-over-year to $16.1 million; the TTM figure through Apr 2026 stood at $66.3 million (down 13.2% YoY), while the FY2026 annual figure was $69.2 million, down 10.29% from the prior year.
  • Interest & Investment Income for Q2 2026 stood at $16.1 million, down from $17.4 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $23.1 million in Q3 2023, with the low at $1.8 million in Q2 2022.
  • The 5-year median for Interest & Investment Income is $17.4 million (2026), against an average of $16.6 million.
  • Peak annual rise in Interest & Investment Income reached 1078.9% in 2022, while the deepest fall reached 32.07% in 2022.
  • Exelixis' Interest & Investment Income stood at $17.0 million in 2022, then grew by 25.9% to $21.4 million in 2023, then retreated by 12.53% to $18.7 million in 2024, then declined by 14.9% to $15.9 million in 2025, then rose by 1.29% to $16.1 million in 2026.
  • Business Quant data shows EXEL's Interest & Investment Income at $16.1 million in Q2 2026, $17.4 million in Q1 2026, and $15.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 48.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 35.58 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 5.13 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 10.98 Mn
10 Exelixis 14.81 Bn 13.97 Bn 608.03 Mn 14.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 14.21 Mn
Apr 3, 2026 16.13 Mn
Jan 2, 2026 17.43 Mn
Oct 3, 2025 15.92 Mn
Jul 4, 2025 16.79 Mn
Apr 4, 2025 19.08 Mn
Jan 3, 2025 21.30 Mn
Sep 27, 2024 18.71 Mn
Jun 28, 2024 17.26 Mn
Mar 29, 2024 19.89 Mn
Dec 29, 2023 21.39 Mn
Sep 29, 2023 23.11 Mn
Jun 30, 2023 22.54 Mn
Mar 31, 2023 19.50 Mn
Dec 30, 2022 16.99 Mn
Sep 30, 2022 9.50 Mn
Jul 1, 2022 4.76 Mn
Apr 1, 2022 1.82 Mn
Dec 31, 2021 1.44 Mn
Oct 1, 2021 1.66 Mn